Treatment resistance in severe unipolar depression: No association with psychotic or melancholic features

Annals of Clinical Psychiatry

Volumn 25, Issue 2, 2013, Pages 97-106

  Zaninotto, Leonardo ^a,b   Souery, Daniel ^c,d   Calati, Raffaella ^e   Sentissi, Othman ^f   Kasper, Siegfried ^g   Akimova, Elena ^g   Zohar, Joseph ^h   Montgomery, Stuart ⁱ   Mendlewicz, Julien ^c   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d Centre Européen de Psychologie Médicale PSY PLURIEL   (Belgium)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h SHEBA MEDICAL CENTER   (Israel)

ⁱ IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Antidepressant; Major depression; Melancholic; Psychotic; Resistant

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PRIORITY JOURNAL; SCORING SYSTEM; SEASONAL VARIATION; TREATMENT FAILURE; TREATMENT RESPONSE; AFFECTIVE DISORDERS, PSYCHOTIC; CLASSIFICATION; CLINICAL TRIAL; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84886881149     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1980.
2. Akiskal HS, McKinney WT Jr. Depressive disorders: toward a unified hypothesis. Science. 1973;182:20-29.
3. Akiskal HS, McKinney WT Jr. Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame. Arch Gen Psychiatry. 1975;32:285-305.
4. Shankman SA, Klein DN. Dimensional diagnosis of depression: adding the dimension of course to severity, and comparison to the DSM. Compr Psychiatry. 2002;43:420-426.
5. Judd LL, Schettler PJ, Akiskal HS. The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am. 2002;25:685-698.
6. Quinn C, Harris A, Kemp A. The Interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and nonmelancholia in an outpatient sample. J Int Neuropsychol Soc. 2012;18:361-369.
7. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 1992;149:733-745.
8. Parker G. Classifying depression: should paradigms lost be regained? Am J Psychiatry. 2000;157:1195-1203.
9. Parker G, Fink M, Shorter E, et al. Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010;167:745-747.
10. Parker G, Hadzi-Pavlovic D. Melancholia. A disorder of movement and mood. Cambridge, United Kingdom: Cambridge University Press; 1996.
11. Parker G. Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand Suppl. 2007:21-30.
12. Parker G, Hadzi-Pavlovic D, Wilhelm K, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994;164:316-326.
13. Parker G, Hadzi-Pavlovic D, Brodaty H, et al. Subtyping depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med. 1995;25:825-832.
14. Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry. 1997;154:4-17.
15. Parker G, Roussos J, Mitchell P, et al. Distinguishing psychotic depression from melancholia. J Affect Disord. 1997;42:155-167.
16. Carroll BJ. Neurobiologic dimensions of depression and mania. In: Angst J, ed. The origins of depression: current concepts and approaches. Berlin, Germany: Springer Verlag; 1983:163-186.
17. Fountoulakis KN, Iacovides A, Gerasimou G, et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:537-546.
18. Taylor MA, Fink M. Melancholia. The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, United Kingdom: Cambridge University Press; 2006.
19. Thase ME, Kupfer DJ, Ulrich RF. Electroencephalographic sleep in psychotic depression. A valid subtype? Arch Gen Psychiatry. 1986;43:886-893.
20. Brown RP, Stoll PM, Stokes PE, et al. Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res. 1988;23:167-178.
21. Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry. 1997;154:1497-1503.
22. Keller J, Flores B, Gomez RG, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60:275-281.
23. Contreras F, Menchon JM, Urretavizcaya M, et al. Hormonal differences between psychotic and nonpsychotic melancholic depression. J Affect Disord. 2007;100:65-73.
24. Potash JB. Carving chaos: genetics and the classification of mood and psychotic syndromes. Harv Rev Psychiatry. 2006;14:47-63.
25. Frank E, Kupfer DJ, Hamer T, et al. Maintenance treatment and psychobiologic correlates of endogenous subtypes. J Affect Disord. 1992;25:181-189.
26. Parker G, Hadzi-Pavlovic D, Brodaty H, et al. Predicting the course of melancholic and nonmelancholic depression. A naturalistic comparison study. J Nerv Ment Dis. 1992;180:693-702.
27. Thase ME, Friedman ES. Is psychotherapy an effective treatment for melancholia and other severe depressive states? J Affect Disord. 1999;54:1-19.
28. Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006;51:114-119.
29. Coryell W, Tsuang MT. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry. 1982;39:1181-1184.
30. Coryell W. Psychotic depression. J Clin Psychiatry. 1996;57(suppl 3):27-31; discussion 49.
31. Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry. 1985;142:430-436.
32. Parker G, Roy K, Hadzi-Pavlovic D, et al. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord. 1992;24:17-24.
33. Chan CH, Janicak PG, Davis JM, et al. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry. 1987;48:197-200.
34. Coryell W, Turner R. Outcome with desipramine therapy in subtypes of nonpsychotic major depression. J Affect Disord. 1985;9:149-154.
35. Angst J, Stabl M. Efficacy of moclobemide in different patient groups: a meta-analysis of studies. Psychopharmacology (Berl). 1992;106(suppl): S109-S113.
36. Peselow ED, Sanfilipo MP, Difiglia C, et al. Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry. 1992;149:1324-1334.
37. Perry PJ. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord. 1996;39:1-6.
38. Mallinckrodt CH, Watkin JG, Liu C, et al. Duloxetine in the treatment of major depressive disorder: a comparison of efficacy in patients with and without melancholic features. BMC Psychiatry. 2005;5:1.
39. McGrath PJ, Khan AY, Trivedi MH, et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry. 2008;69:1847-1855.
40. Souery D, Oswald P, Massat I, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68:1062-1070.
41. Carroll BJ. Bringing back melancholia. Bipolar Disord. 2012;14:1-5.
42. Ioannidis JP. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med. 2008;3:14.
43. Pigott HE, Leventhal AM, Alter GS, et al. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom. 2010;79:267-279.
44. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
45. Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history? J Affect Disord. 2003;75:115-124.
46. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33;quiz 4-57.
47. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
48. European Agency for the Evaluation of Medicinal Products. Note for guidance on clinical investigation of medicinal products in the treatment of depression. http://www.emea.europa.eu/pdfs/human/ewp/ 051897en.pdf. Published April 25, 2002. Accessed January 29, 2013.
49. StatSoft I, STATISTICA for Windows. 1995.
50. Diagnostic and statistical manual of mental disorders, 4th ed, text rev. Washington DC: American Psychiatric Association; 2000.
51. Coryell W, Winokur G, Shea T, et al. The longterm stability of depressive subtypes. Am J Psychiatry. 1994;151:199-204.
52. Coryell W, Leon A, Winokur G, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry. 1996;153:483-489.
53. Glassman AH, Roose SP. Delusional depression. A distinct clinical entity? Arch Gen Psychiatry. 1981;38:424-427.
54. Frances A, Brown RP, Kocsis JH, et al. Psychotic depression: a separate entity? Am J Psychiatry. 1981;138:831-833.
55. Parker G, Hadzi-Pavlovic D, Hickie I, et al. Psychotic depression: a review and clinical experience. Aust N Z J Psychiatry. 1991;25:169-180.
56. Souery D, Zaninotto L, Calati R, et al. Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. J Affect Disord. 2011;135:241-250.
57. Hildebrandt MG, Stage KB, Kragh-Soerensen P; Danish University Antidepressant Group. Gender differences in severity, symptomatology and distribution of melancholia in major depression. Psychopathology. 2003;36:204-212.
58. Khan AY, Carrithers J, Preskorn SH, et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry. 2006;18:91-98.
59. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7:254-275.
60. Angst J, Gamma A, Benazzi F, et al. Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr Scand Suppl. 2007:72-84.
61. Coryell W. The facets of melancholia. Acta Psychiatr Scand Suppl. 2007:31-36.
62. Winthorst WH, Post WJ, Meesters Y, et al. Seasonality in depressive and anxiety symptoms among primary care patients and in patients with depressive and anxiety disorders; results from the Netherlands Study of Depression and Anxiety. BMC Psychiatry. 2011;11:198.
63. Gaudiano BA, Beevers CG, Miller IW. Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression. J Nerv Ment Dis. 2005;193:625-628.
64. Harald B, Gordon P. Meta-review of depression subtyping models. J Affect Disord. 2012;139:126-140.
65. Lux V, Aggen SH, Kendler KS. The DSM-IV definition of severity of major depression: inter-relationship and validity. Psychol Med. 2010;40:1691-1701.